Mixed-amphetamine salts, extended release for cognitive impairment in persons with MS, a randomized controlled trial.
Multiple sclerosis and related disorders · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
AdultFemaleHumansMaleMiddle AgedAmphetaminesCentral Nervous System StimulantsCognitive DysfunctionCognitive EnhancementDelayed-Action PreparationsDouble-Blind MethodOutcome Assessment, Health CareAdderall XRCognitionCognitive impairmentExtended release (MAS-XR)Information processing speedMixed amphetamine saltsMultiple sclerosis
Come citare questo studio
Sarah A Morrow, Heather Rosehart, Penelope Smyth, Pamala Dumont, Marina Everest, Michael Thorne, Liesly Lee. (2026). Mixed-amphetamine salts, extended release for cognitive impairment in persons with MS, a randomized controlled trial.. Multiple sclerosis and related disorders. DOI: 10.1016/j.msard.2026.107932
Consulta la pubblicazione originale ↗